Stock-based Compensation (Details) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) Offering_Period $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Share-based Payment Arrangement, Additional Disclosure [Abstract]
Proceeds from issuance of common stock | $	$ 136,000	$ 229,000	$ 79,000
Employee Stock Purchase Plan [Abstract]
Granted	0	0	0
Stock Incentive Plans
Share-based Compensation Arrangement by Share-based Payment Award
Stock-based compensation cost | $	$ 219,000	$ 219,000	$ 214,000
Tax benefit | $	(36,000)	(33,000)	(32,000)
Stock-based compensation cost, net of tax | $	$ 183,000	$ 186,000	182,000
Number of shares reserved for issuance to recipient (in shares)	264,000
Number of shares available for future grant (in shares)	11,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Expiration from date of award (in years)	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period	18,200
Exercised	(1,600)
Forfeited/expired	(2,300)
Outstanding at end of period	14,300	18,200
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Outstanding- weighted average exercise price at beginning of period (in dollars per share) | $ / shares	$ 43.88
Exercised | $ / shares	28.14
Forfeited/expired | $ / shares	45.07
Outstanding- weighted average price per share end of period (in dollars per share) | $ / shares	$ 45.47	$ 43.88
Weighted Average Remaining Contractual Term (years)	2 years 8 months 12 days
Aggregate Intrinsic Value | $	$ 27,200
Number of shares exercisable at the end of the period	14,300
Weighted Average Exercise Price per Share, Exercisable at the end of the period | $ / shares	$ 45.47
Weighted Average Remaining Contractual Term (years), Exercisable at the end of the period	2 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable at the end of the Period | $	$ 27,200
Intrinsic value of stock options exercised during the period | $	20,000	$ 43,000	315
Share-based Payment Arrangement, Additional Disclosure [Abstract]
Unrecognized compensation cost, non vested awards at period end | $	0
Proceeds from issuance of common stock | $	$ 136,000	229,000	79,000
Stock Options | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Vesting period	3 years
Exercise of stock options [Member]
Share-based Payment Arrangement, Additional Disclosure [Abstract]
Proceeds from issuance of common stock | $	$ 48,000	$ 148,000	$ 4,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares reserved for issuance to recipient (in shares)	104,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected volatility	48.00%	46.00%	69.00%
Expected dividend yield	1.44%	1.67%	0.84%
Risk-free interest rate	5.11%	1.42%	0.05%
Weighted average grant-date fair value of option | $ / shares	$ 7.16	$ 5.63	$ 5.01
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Shares available for future issuance through the plan	28,000
Employee Stock Purchase Plan [Abstract]
Percentage of earnings eligible employees may have withheld under the employee stock purchase plan	10.00%
Number of offering periods | Offering_Period	4
Percentage of the lower of fair market value of the unit on the commencement date or the fair market value of unit on the last trading day of the offering period	90.00%
Number of shares sold through the plan (in shares)	76,000
Restricted Stock And Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Nonvested shares at the beginning of the period	22,100
Granted	7,600
Vested	(8,000)
Forfeited	(800)
Non vested shares at the end of the period	20,900	22,100
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant-Date Fair Value per Share, Non vested shares at the beginning of the period | $ / shares	$ 24.83
Granted | $ / shares	31.73	$ 31.40	$ 20.94
Vested | $ / shares	24.47
Forfeited | $ / shares	26.35
Weighted Average Grant-Date Fair Value Per Share, Nonvested shares at the end of the period | $ / shares	$ 27.42	$ 24.83
Total fair value of shares vested during the period | $	$ 283,000	$ 248,000	$ 117,000
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Expiration from date of award (in years)	5 years
Share-based Payment Arrangement, Additional Disclosure [Abstract]
Unrecognized compensation cost, non vested awards at period end | $	$ 377,000
Weighted average period unrecognized compensation costs to be recognized (in years)	3 years